A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia

Craig L. Donnelly, Joseph Patrick McEvoy, William H. Wilson, Nedarthur Narasimhachari

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Ten men inpatients who met DSM-III-R criteria for schizophrenia participated. On five occasions at least one week apart, each subject had an intravenous line placed at 0730 afer an overnight fast. On each occasion blood samples were drawn at 0800 and hourly thereafter through 1200 noon for measurement of plasma homovanillic acid (HVA). Total four-hour urine collections were obtained for measurement of urinary HVA. Subjects received five experimental conditions, in randomized sequence; no intervention, smoking one cigarette per hour, drinking one caffeinated cola per hour, lorazepam 2 mg IV push, or a high monoamine meal. Baseline (0800) plasma HVA measures showed only minor intrinsic variability. The average standard deviation in baseline plasma HVA over five occasions of measurement was low relative to the changes in HVA produced during treatment with antipsychotic medications. The high monoamine meal significantly elevated plasma HVA, with a similar trend for urinary HVA. Neither caffeine, nicotine, nor lorazepam significantly affected plasma or urinary HVA.

Original languageEnglish (US)
Pages (from-to)1218-1221
Number of pages4
JournalBiological Psychiatry
Volume40
Issue number12
DOIs
StatePublished - Dec 15 1996
Externally publishedYes

Fingerprint

Lorazepam
Homovanillic Acid
Caffeine
Nicotine
Schizophrenia
Diet
Meals
Urine Specimen Collection
Diagnostic and Statistical Manual of Mental Disorders
Antipsychotic Agents
Drinking
Inpatients
Smoking

Keywords

  • caffeine
  • homovanillic acid
  • lorazepam
  • nicotine
  • schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia. / Donnelly, Craig L.; McEvoy, Joseph Patrick; Wilson, William H.; Narasimhachari, Nedarthur.

In: Biological Psychiatry, Vol. 40, No. 12, 15.12.1996, p. 1218-1221.

Research output: Contribution to journalArticle

@article{3cdb219ddde44b6d8d445b68736792f0,
title = "A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia",
abstract = "Ten men inpatients who met DSM-III-R criteria for schizophrenia participated. On five occasions at least one week apart, each subject had an intravenous line placed at 0730 afer an overnight fast. On each occasion blood samples were drawn at 0800 and hourly thereafter through 1200 noon for measurement of plasma homovanillic acid (HVA). Total four-hour urine collections were obtained for measurement of urinary HVA. Subjects received five experimental conditions, in randomized sequence; no intervention, smoking one cigarette per hour, drinking one caffeinated cola per hour, lorazepam 2 mg IV push, or a high monoamine meal. Baseline (0800) plasma HVA measures showed only minor intrinsic variability. The average standard deviation in baseline plasma HVA over five occasions of measurement was low relative to the changes in HVA produced during treatment with antipsychotic medications. The high monoamine meal significantly elevated plasma HVA, with a similar trend for urinary HVA. Neither caffeine, nicotine, nor lorazepam significantly affected plasma or urinary HVA.",
keywords = "caffeine, homovanillic acid, lorazepam, nicotine, schizophrenia",
author = "Donnelly, {Craig L.} and McEvoy, {Joseph Patrick} and Wilson, {William H.} and Nedarthur Narasimhachari",
year = "1996",
month = "12",
day = "15",
doi = "10.1016/0006-3223(95)00650-8",
language = "English (US)",
volume = "40",
pages = "1218--1221",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "12",

}

TY - JOUR

T1 - A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia

AU - Donnelly, Craig L.

AU - McEvoy, Joseph Patrick

AU - Wilson, William H.

AU - Narasimhachari, Nedarthur

PY - 1996/12/15

Y1 - 1996/12/15

N2 - Ten men inpatients who met DSM-III-R criteria for schizophrenia participated. On five occasions at least one week apart, each subject had an intravenous line placed at 0730 afer an overnight fast. On each occasion blood samples were drawn at 0800 and hourly thereafter through 1200 noon for measurement of plasma homovanillic acid (HVA). Total four-hour urine collections were obtained for measurement of urinary HVA. Subjects received five experimental conditions, in randomized sequence; no intervention, smoking one cigarette per hour, drinking one caffeinated cola per hour, lorazepam 2 mg IV push, or a high monoamine meal. Baseline (0800) plasma HVA measures showed only minor intrinsic variability. The average standard deviation in baseline plasma HVA over five occasions of measurement was low relative to the changes in HVA produced during treatment with antipsychotic medications. The high monoamine meal significantly elevated plasma HVA, with a similar trend for urinary HVA. Neither caffeine, nicotine, nor lorazepam significantly affected plasma or urinary HVA.

AB - Ten men inpatients who met DSM-III-R criteria for schizophrenia participated. On five occasions at least one week apart, each subject had an intravenous line placed at 0730 afer an overnight fast. On each occasion blood samples were drawn at 0800 and hourly thereafter through 1200 noon for measurement of plasma homovanillic acid (HVA). Total four-hour urine collections were obtained for measurement of urinary HVA. Subjects received five experimental conditions, in randomized sequence; no intervention, smoking one cigarette per hour, drinking one caffeinated cola per hour, lorazepam 2 mg IV push, or a high monoamine meal. Baseline (0800) plasma HVA measures showed only minor intrinsic variability. The average standard deviation in baseline plasma HVA over five occasions of measurement was low relative to the changes in HVA produced during treatment with antipsychotic medications. The high monoamine meal significantly elevated plasma HVA, with a similar trend for urinary HVA. Neither caffeine, nicotine, nor lorazepam significantly affected plasma or urinary HVA.

KW - caffeine

KW - homovanillic acid

KW - lorazepam

KW - nicotine

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0030589558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030589558&partnerID=8YFLogxK

U2 - 10.1016/0006-3223(95)00650-8

DO - 10.1016/0006-3223(95)00650-8

M3 - Article

C2 - 8959286

AN - SCOPUS:0030589558

VL - 40

SP - 1218

EP - 1221

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 12

ER -